Edition:
United Kingdom

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

7.82USD
5:16pm GMT
Change (% chg)

$0.09 (+1.23%)
Prev Close
$7.72
Open
$7.69
Day's High
$7.92
Day's Low
$7.60
Volume
382,300
Avg. Vol
1,604,067
52-wk High
$17.99
52-wk Low
$5.77

Chart for

About

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that... (more)

Overall

Beta: 0.59
Market Cap(Mil.): $1,915.85
Shares Outstanding(Mil.): 223.29
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

16 Nov 2017

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK, Nov 16 A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

16 Nov 2017

Earnings vs. Estimates